Evidence for the dysregulated expression of TWIST1, TGFβ1 and SMAD3 in differentiating osteoblasts from primary hip osteoarthritis patients

Osteoarthritis and Cartilage

Volumn 20, Issue 11, 2012, Pages 1357-1366

  Kumarasinghe, D D ^a,b   Sullivan, T ^a   Kuliwaba, J S ^a,b   Fazzalari, N L ^a,b   Atkins, G J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Bone and Joint Research Laboratory   (Australia)

Author keywords

Energy dispersive X ray spectroscopy; Gene expression; Hip osteoarthritis; Mineral composition; Mineralisation; Primary osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; MESSENGER RNA; MINERAL; OSTEOCALCIN; PHOSPHOROUS ACID; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT5B PROTEIN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HIP OSTEOARTHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; OSTEOBLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROENTGEN SPECTROSCOPY; TRABECULAR BONE; TWIST HOMOLOGUE 1 GENE;

AGED; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FEMUR HEAD; GENE EXPRESSION; HUMANS; NUCLEAR PROTEINS; OSTEOARTHRITIS, HIP; OSTEOBLASTS; PHOSPHORUS; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TWIST TRANSCRIPTION FACTOR;

EID: 84866453777     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.07.005     Document Type: Article

References (52)

1. Buckwalter J.A., Saltzman C., Brown T. The impact of osteoarthritis. Clin Orthop Relat Res 2004, 427S:S6-S15.
2. Felson D.T., Lawrence R.C., Dieppe P.A., Hirsch R., Helmick C.G., Jordan J.M., et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000, 133:635-646.
3. Brandt K.D., Radin E.L., Dieppe P.A., van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis 2006, 65:1261-1264.
4. Dequeker J., Mokassa L., Aerssens J. Bone density and osteoarthritis. J Rheumatol 1995, 43(Suppl):98-100.
5. Dequeker J., Mokassa L., Aerssens J., Boonen S. Bone density and local growth factors in generalized osteoarthritis. Microsc Res Tech 1997, 37:358-371.
6. Luyten F.P., Tylzanowski P., Lories R.J. WNT signaling and osteoarthritis. Bone 2009, 44:522-527.
7. Spector T.D., MacGregor A.J. Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage 2004, 12:S39-S44.
8. Hopwood B., Tsykin A., Findlay D.M., Fazzalari N.L. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-B/bone morphogenetic protein signalling. Arthritis Res Ther 2007, 9:1-21.
9. Sánchez-Sabaté E., Alvarez L., Gil-Garay E., Munuera L., Vilaboa N. Identification of differentially expressed genes in trabecular bone from the iliac crest of osteoarthritic patients. Osteoarthritis Cartilage 2009, 17:1106-1114.
10. Li B., Aspden R.M. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis and osteoarthritis. J Bone Miner Res 1997, 12:641-651.
11. Kumarasinghe D.D., Perilli E., Tsangari H., Truong L., Kuliwaba J.S., Hopwood B., et al. Critical molecular regulators, histomorphometric indices and their correlations in the trabecular bone in primary hip osteoarthritis. Osteoarthritis Cartilage 2010, 18:1337-1344.
12. Collins D.H. The Pathology of Articular and Spinal Diseases 1949, Edward Arnold, London.
13. Kumarasinghe D.D., Hopwood B., Kuliwaba J.S., Atkins G.J., Fazzalari N.L. An update on primary hip osteoarthritis including altered Wnt and TGF-β associated gene expression from the bony component of the disease. Rheumatology 2011, 50:2166-2175.
14. Logar D.B., Komadina R., Preželj J., Ostanek B., Trošt Z., Marc J. Expression of bone resorption genes in osteoarthritis and in osteoporosis. J Bone Miner Metab 2007, 25:219-225.
15. Giner M., Rios M.J., Montoya M.J., Vázquez M.A., Naji L., Pérez-Cano R. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. J Steroid Biochem Mol Biol 2009, 113:46-51.
16. Hernández J.L., Garcés C.M., Sumillera M., Fernández-Aldasoro E.V., García-Ibarbia C., Ortiz-Gómez J.A., et al. Aromatase expression in osteoarthritic and osteoporotic bone. Arthritis Rheum 2008, 58:1696-1700.
17. Velasco J., Zarrabeitia M.T., Prieto J.R., Perez-Castrillon J.L., Perez-Aguilar M.D., Perez-Nunez M.I., et al. WNT pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study. Osteoporos Int 2009, 21:109-118.
18. Truong L.-H., Kuliwaba J.S., Tsangari H., Fazzalari N.L. Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients. Arthritis Res Ther 2006, 8:R188.
19. Atkins G.J., Anderson P.H., Findlay D.M., Welldon K.J., Vincent C., Zannettino A.C.W., et al. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1[alpha],25-dihydroxyvitamin D3. Bone 2007, 40:1517-1528.
20. Atkins G.J., Welldon K.J., Halbout P., Findlay D.M. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporos Int 2009, 20:653-664.
21. Atkins G.J., Rowe P.S., Lim H.P., Welldon K.J., Ormsby R., Wijenayaka A.R., et al. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res 2011, 26:1425-1436.
22. Atkins G.J., Welldon K.J., Wijenayaka A.R., Bonewald L.F., Findlay D.M. Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by γ-carboxylation-dependent and -independent mechanisms. Am J Physiol Cell Physiol 2009, 297:C1358-C1367.
23. Atkins G.J., Kostakis P., Pan B., Farrugia A., Gronthos S., Evdokiou A., et al. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 2003, 18:1088-1098.
24. Sutherland M.S.K., Rao L.G., Muzaffar S.A., Wylie J.N., Wong M.M., McBroom R.J., et al. Age-dependent expression of osteoblastic phenotypic markers in normal human osteoblasts cultured long term in the presence of dexamethasone. Osteoporos Int 1995, 5:335-343.
25. Carpentier V.T., Wong J., Yeap Y., Gan C., Sutton-Smith P., Badiei A., et al. Increased proportion of hypermineralized osteocyte lacunae in osteoporotic and osteoarthritic human trabecular bone: implications for bone remodeling. Bone 2012, 50:688-694.
26. Bloebaum R.D., Holmes J.L., Skedros J.G. Mineral content changes in bone associated with damage induced by the electron beam. Scanning 2005, 27:240-248.
27. Roschger P., Plenk H., Klaushofer K., Eschberger J. A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities. Scanning Microsc 1995, 9:75-86. Discussion 86-78.
28. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:2002-2007.
29. Brown H., Prescott R. Applied Mixed Models in Medicine 2006, John Wiley & Sons, Edinburgh. 2nd edn.
30. Akesson K., Grynpas M.D., Hancock R.G.V., Odselius R., Obrant K.J. Energy-dispersive X-ray microanalysis of the bone mineral content in human trabecular bone: a comparison with ICPES and neutron activation analysis. Calcif Tissue Int 1994, 55:236-239.
31. Duplomb L., Dagouassat M., Jourdon P., Heymann D. Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation. Stem Cell 2007, 25:544-552.
32. Li B., Aspden R.M. Material properties of bone from the femoral neck and calcar femorale of patients with osteoporosis or osteoarthritis. Osteoporos Int 1997, 7:450-456.
33. Li B., Aspden R.M. Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997, 56:247-254.
34. Li B., Marshall D., Roe M., Aspden R.M. The electron microscope appearance of the subchondral bone plate in the human femoral head in osteoarthritis and osteoporosis. J Anat 1999, 195:101-110.
35. Grynpas M., Alpert B., Katz I., Lieberman I., Pritzker K. Subchondral bone in osteoarthritis. Calcif Tissue Int 1991, 49:20-26.
36. Pramanik S., Agarwal A.K., Rai K.N. Development of high strength hydroxyapatite for hard tissue replacement. Trends Biomater Artif Organs 2005, 19:46-51.
37. Borton A.J., Frederick J.P., Datto M.B., Wang X.-F., Weinstein R.S. The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res 2001, 16:1754-1764.
38. Bialek P., Kern B., Yang X., Schrock M., Sosic D., Hong N., et al. A twist code determines the onset of osteoblast differentiation. Dev Cell 2004, 6:423-435.
39. Murshed M., Harmey D., Millán J.L., McKee M.D., Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Gene Dev 2005, 19:1093-1104.
40. Shi Q., Lajeunesse D., Reboul P., Martel-Pelletier J., Pelletier J.P., Dehnade F., et al. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening. J Rheumatol 2002, 29:1437-1445.
41. Janssens K., ten Dijke P., Janssens S., Hul W.V. Transforming growth factor-beta1 to the bone. Endocr Rev 2005, 26:743-774.
42. Alliston T., Choy L., Ducy P., Karsenty G., Derynck R. TGFβ-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001, 20:2254-2272.
43. Maeda S., Hayashi M., Komiya S., Imamura T., Miyazono K. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 2004, 23:552-563.
44. Kassem M., Kveiborg M., Eriksen E.F. Production and action of transforming growth factor-B; in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol. Eur J Clin Investig 2000, 30:429-437.
45. Hurson C.J., Butler J.S., Keating D.T., Murray D.W., Sadlier D.M., O'Byrne J.M., et al. Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis. BMC Muscoskel Disord 2007, 8:12.
46. van Tienen F.H.J., Laeremans H., van der Kallen C.J.H., Smeets H.J.M. WNT5b stimulates adipogenesis by activating PPAR[gamma], and inhibiting the [beta]-catenin dependent WNT signaling pathway together with Wnt5a. Biochem Biophys Res Commn 2009, 387:207-211.
47. Balooch G., Balooch M., Nalla R.K., Schilling S., Filvaroff E.H., Marshall G.W., et al. TGF-β regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci USA 2005, 102:18813-18818.
48. Corrado A., Neve A., Cantatore F.P. Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. Clin Exp Med 2011, 29:29.
49. Varoga D., Drescher W., Pufe M., Groth G., Pufe T. Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head. Clin Orthop Relat Res 2009, 467:3273-3282.
50. Zini N., Bavelloni A., Lisignoli G., Ghisu S., Valmori A., Martelli A.M., et al. PKC-zeta expression is lower in osteoblasts from arthritic patients: IL1-beta and TNF-alpha induce a similar decrease in non-arthritic human osteoblasts. J Cell Biochem 2008, 103:547-555.
51. Lavigne P., Benderdour M., Lajeunesse D., Shi Q., Fernandes J.C. Expression of ICAM-1 by osteoblasts in healthy individuals and in patients suffering from osteoarthritis and osteoporosis. Bone 2004, 35:463-470.
52. Gangji V., Hauzeur J.P., Schoutens A., Hinsenkamp M., Appelboom T., Egrise D. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 2003, 30:348-351.